XML 57 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional paid-in capital
Deficit
Accumulated other comprehensive loss
Shares, Issued, Beginning Balance at Dec. 31, 2021   144,987,736      
Beginning balance at Dec. 31, 2021 $ 169,439 $ 1,286,636 $ 65,485 $ (1,134,347) $ (48,335)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 7,182   7,182    
Certain fair value adjustments to liability stock option awards 26   26    
Issuance of common shares pursuant to the Open Market Sales Agreement (in shares)   8,645,426      
Issuance of common shares pursuant to the Open Market Sales Agreement $ 20,324 $ 20,324      
Issuance of common shares pursuant to exercise of ESPP options (in shares) 171,224 171,224      
Issuance of common shares pursuant to exercise of ESPP $ 395 $ 588 (193)    
Issuance of common shares pursuant to Share Purchase Agreement (in shares)   3,579,952      
Issuance of common shares pursuant to exercise of stock options 10,973 $ 10,973      
Issuance of common shares pursuant to exercise of options (in shares)   71,025      
Issuance of common shares pursuant to exercise of stock options 122 $ 216 (94)    
Unrealized gain (loss) on available-for-sale securities (2,153)       (2,153)
Net loss (69,456)     (69,456)  
Ending balance (in shares) at Dec. 31, 2022   157,455,363      
Ending balance at Dec. 31, 2022 136,852 $ 1,318,737 72,406 (1,203,803) (50,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 9,301   9,301    
Issuance of common shares pursuant to the Open Market Sales Agreement (in shares)   12,020,257      
Issuance of common shares pursuant to the Open Market Sales Agreement $ 29,852 $ 29,852      
Issuance of common shares pursuant to exercise of ESPP options (in shares) 290,438 290,438      
Issuance of common shares pursuant to exercise of ESPP $ 535 $ 774 (239)    
Issuance of common shares pursuant to exercise of options (in shares)   101,356      
Issuance of common shares pursuant to exercise of stock options 260 $ 458 (198)    
Unrealized gain (loss) on available-for-sale securities 2,067       2,067
Net loss (72,849)     (72,849)  
Ending balance (in shares) at Dec. 31, 2023   169,867,414      
Ending balance at Dec. 31, 2023 $ 106,018 $ 1,349,821 $ 81,270 $ (1,276,652) $ (48,421)